razoxane has been researched along with Hodgkin Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conde-Estévez, D; Mateu-de Antonio, J; Salar, A; Saumell, S | 1 |
| Drake, D | 1 |
| Chauvenet, A; de Alarcón, PA; Fitzgerald, TJ; Hutchison, RE; London, WB; Mendenhall, NP; Schwartz, C; Tebbi, CK; Williams, JL | 1 |
| Gisterek, I; Mazur, G; Wróbel, T; Włodarska, I; Zymliński, R; Łacko, A | 1 |
| Chauvenet, A; Constine, LS; De Alarcon, PA; Friedman, D; London, WB; Mendenhall, NP; Schwartz, CL; Sposto, R; Tebbi, CK; Villaluna, D | 1 |
| Lipshultz, SE; Lipsitz, SR; Orav, EJ | 1 |
| Hellmann, K | 1 |
| Asselin, BL; Athale, UH; Barry, EV; Clavell, LA; Cohen, HJ; Dahlberg, SE; Larsen, EC; Lipshultz, SE; Moghrabi, A; Neuberg, DS; Sallan, SE; Samson, Y; Schorin, MA; Silverman, LB; Vrooman, LM | 1 |
| Bell, SJ; Corder, MP; McFadden, DB | 1 |
| Begg, CB; Glick, JH; O'Connell, MJ; Oken, MM; Silverstein, MN | 1 |
| Bernadic, M; Foltinová, A; Hulín, I; Mladosievicova, B; Petrásová, H | 1 |
| Das, S; Freedman, LS; Garrett, MJ; Smith, JD | 1 |
| Das, S; Garrett, MJ | 1 |
| Forbes, JF | 1 |
3 review(s) available for razoxane and Hodgkin Disease
| Article | Year |
|---|---|
BET 3: emergency management of anthracycline extravasation.
Topics: Adult; Antibiotics, Antineoplastic; Chelating Agents; Doxorubicin; Emergency Service, Hospital; Extravasation of Diagnostic and Therapeutic Materials; Hodgkin Disease; Humans; Male; Razoxane | 2012 |
[Cardiac toxicity in cancer therapy].
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cardiomyopathy, Dilated; Cardiovascular Agents; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasms; Radiotherapy, Adjuvant; Razoxane; Risk Factors; Sarcoma | 2002 |
Long-term effects of adjuvant chemotherapy in breast cancer.
Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Heart; Heart Diseases; Hodgkin Disease; Humans; Leukemia; Lymphatic Metastasis; Menopause; Menstruation; Monitoring, Physiologic; Neoplasms, Second Primary; Ovary; Razoxane | 1992 |
6 trial(s) available for razoxane and Hodgkin Disease
| Article | Year |
|---|---|
Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Razoxane; Remission Induction; Survival Rate; Vincristine; Young Adult | 2012 |
Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chelating Agents; Cohort Studies; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid; Lung Diseases; Male; Myelodysplastic Syndromes; Neoplasm Staging; Neoplasms, Second Primary; Osteosarcoma; Razoxane; Risk Assessment; Risk Factors; Thyroid Neoplasms; Time Factors; Topoisomerase II Inhibitors | 2007 |
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Infant; Infant, Newborn; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Survival Rate | 2008 |
A trial of razoxane (ICRF-159) in patients with prior therapy for Hodgkin's lymphoma.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Male; Middle Aged; Piperazines; Razoxane | 1984 |
Randomized clinical trial comparing two dose regimens of ICRF-159 in refractory malignant lymphomas.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Myeloproliferative Disorders; Piperazines; Probability; Prognosis; Razoxane; Thrombocytopenia | 1980 |
Signal-averaged electrocardiography in survivors of Hodgkin's disease treated with and without dexrazoxane.
Topics: Adolescent; Antineoplastic Agents; Arrhythmias, Cardiac; Cardiomyopathies; Cardiovascular Agents; Child; Child, Preschool; Combined Modality Therapy; Doxorubicin; Electrocardiography; Female; Fourier Analysis; Hodgkin Disease; Humans; Infant; Male; Razoxane | 2001 |
5 other study(ies) available for razoxane and Hodgkin Disease
| Article | Year |
|---|---|
Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin.
Topics: Adult; Antibiotics, Antineoplastic; Doxorubicin; Extravasation of Diagnostic and Therapeutic Materials; Hodgkin Disease; Humans; Male; Razoxane; Treatment Outcome | 2010 |
Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasms, Second Primary; Randomized Controlled Trials as Topic; Razoxane; Risk Assessment; Scientific Misconduct; Sensitivity and Specificity; Survival Rate | 2007 |
Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without evidence.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Hodgkin Disease; Humans; Neoplasms; Razoxane; Research Design; Risk; Risk Factors | 2007 |
Long term experience with combination chemotherapy in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Male; Mechlorethamine; Middle Aged; Mutagens; Neoplasms, Multiple Primary; Oxymetholone; Prednisone; Pregnancy; Procarbazine; Razoxane; Teratogens; Vinblastine; Vincristine | 1977 |
Treatment of the lymphomata with ICRF 159 (NSC 129943) adjunctive to combination chemotherapy.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Male; Piperazines; Razoxane | 1977 |